PETV
PetVivo Holdings, Inc.
OTC Markets OTCQXUSDEQUITY
Healthcare
DELAYED
Neutral
+18/100
Last price
0.83
▲ 0.08 (10.59%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
0.75
Day high
0.83
Day low
0.74
Volume
210
Market cap
$31.31M
P/E (TTM)
—
52W range
0.59 – 1.69
Trailing performance
Returnvs SPY
1W
+3.51%
+1.6%
1M
+21.32%
+20.2%
3M
-1.79%
-6.3%
6M
+25.00%
+6.8%
YTD
-27.63%
-41.9%
1Y
-35.55%
-52.0%
3Y
-55.16%
-137.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PETV open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
20.95M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 18, 26 | RUDELIUS ROBERT JAMES Director |
STOCK | 3.50K | $2.56K | Direct |
| Sep 14, 26 | A.L. SARROFF FUND, LLC Beneficial Owner of more than 10% of a Class of Security |
BUY | 58.60K | $40.02K | |
| Sep 9, 26 | LAI JOHN Chief Executive Officer |
STOCK | 31.25K | $24.38K | Direct |
| Sep 9, 26 | LAI JOHN Chief Executive Officer |
STOCK | 31.25K | $25.00K | Direct |
| Sep 8, 26 | LOWENTHAL GARRY N Chief Financial Officer |
STOCK | 31.25K | $25.00K | Indirect |
| Sep 8, 26 | LOWENTHAL GARRY N Chief Financial Officer |
STOCK | 31.25K | $25.00K | Indirect |
| Sep 8, 26 | LOWENTHAL GARRY N Chief Financial Officer |
CONVERSION | 31.25K | $334.38K | Indirect |
| Sep 8, 26 | LOWENTHAL GARRY N Chief Financial Officer |
CONVERSION | 31.25K | $131.25K | Indirect |
| Sep 8, 26 | LAI JOHN Chief Executive Officer |
CONVERSION | 31.25K | $334.38K | Direct |
| Sep 8, 26 | LAI JOHN Chief Executive Officer |
CONVERSION | 31.25K | $131.25K | Direct |
| Jul 21, 26 | LOWENTHAL GARRY N Chief Financial Officer |
STOCK | 75.00K | $57.75K | Indirect |
| Jul 21, 26 | LAI JOHN Chief Executive Officer |
STOCK | 75.00K | $57.75K | Indirect |
| Jun 9, 26 | A.L. SARROFF FUND, LLC Beneficial Owner of more than 10% of a Class of Security |
— | 187.50K | — | Direct |
| May 28, 26 | A.L. SARROFF FUND, LLC Beneficial Owner of more than 10% of a Class of Security |
— | 200.00K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
A.L. SARROFF FUND, LLC |
Beneficial Owner of more than 10% of a Class of Security | — | Purchase |
BREITHAUPT JOHN SPENCER |
Director | 60.19K | Stock Award(Grant) |
COSTANTINO ROBERT J |
Director | 108.66K | Stock Award(Grant) |
ELDRED MICHAEL EUGENE |
Director | 311.81K | Stock Award(Grant) |
JASPER JOSEPH WILLIAM |
Director | 137.16K | Stock Award(Grant) |
LAI JOHN |
Chief Executive Officer | 2.41M | Stock Award(Grant) |
LEVITAN DIANE M |
Director | 71.49K | Stock Award(Grant) |
LOWENTHAL GARRY N |
Chief Financial Officer | — | Stock Award(Grant) |
RUBEN JOSHUA DAVID |
Director | 53.83K | Stock Award(Grant) |
RUDELIUS ROBERT JAMES |
Director | 427.89K | Stock Award(Grant) |
Fundamentals
Market cap$31.31M
Enterprise value$31.71M
Revenue (TTM)$1.18M
Gross profit$791.34K
EBITDA$-7.30M
Net income$-9.87M
EPS (TTM)$-0.34
Free cash flow$-2.22M
Total cash$122.63K
Total debt$515.11K
Book value / share$0.04
Shares outstanding37.95M
Float26.42M
Short % of float1.21%
Dividend yield0.00%
Beta (5Y)1.34
Valuation & profitability ratios
Trailing P/E—
Forward P/E-1.10
PEG ratio—
Price / sales—
Price / book22.92
EV / revenue26.84
EV / EBITDA-4.34
Gross margin66.97%
Operating margin-476.59%
Profit margin0.00%
Return on equity-384.36%
Return on assets-102.35%
Debt / equity37.98
Current ratio0.72
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $1.14M | $1.13M | $968.71K | $917.16K | +0.8% |
| Operating revenue | $1.14M | $1.13M | $968.71K | $917.16K | +0.8% |
| Cost of revenue | $386.86K | $137.68K | $101.82K | $221.04K | +181.0% |
| Gross profit | $754.75K | $994.86K | $866.88K | $696.13K | -24.1% |
| Research & development | $1.42M | $1.58M | $1.40M | $996.36K | -10.6% |
| Selling, general & admin | $7.40M | $7.47M | $10.09M | $8.43M | -0.9% |
| Total operating expense | $8.82M | $9.05M | $11.49M | $9.43M | -2.6% |
| Operating income | -$8.06M | -$8.06M | -$10.62M | -$8.73M | -0.1% |
| Net interest income | -$1.05M | -$359.41K | -$6.46K | $15.84K | -192.9% |
| Pre-tax income | -$10.47M | -$8.40M | -$10.96M | -$8.72M | -24.7% |
| Tax provision | $0 | $0 | $0 | $0 | — |
| Net income | -$10.47M | -$8.40M | -$10.96M | -$8.72M | -24.7% |
| Net income to common | -$10.88M | -$8.40M | -$10.96M | -$8.72M | -29.5% |
| Basic EPS | -0.38 | -0.41 | -0.78 | -0.85 | +7.3% |
| Diluted EPS | -0.38 | -0.41 | -0.78 | -0.85 | +7.3% |
| EBIT | -$9.41M | -$8.04M | -$10.95M | -$8.73M | -17.0% |
| EBITDA | -$8.86M | -$7.69M | -$10.82M | -$8.62M | -15.3% |
| Basic shares | 30.15M | 20.49M | 13.97M | 10.22M | +47.2% |
| Diluted shares | 30.15M | 20.49M | 13.97M | 10.22M | +47.2% |
| Line item | 2026 | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $200.78K | $227.69K | $87.40K | $475.31K | — | -11.8% |
| Cash & short-term investments | $350.78K | $377.69K | $87.40K | $475.31K | — | -7.1% |
| Accounts receivable | $100.84K | $60.57K | $18.67K | $86.69K | — | +66.5% |
| Inventory | $538.37K | $323.50K | $390.08K | $370.28K | — | +66.4% |
| Total current assets | $1.86M | $5.61M | $1.04M | $1.42M | — | -66.8% |
| Property, plant & equipment | $503.59K | $1.73M | $2.02M | $948.83K | — | -70.9% |
| Goodwill & intangibles | $1.20M | $1.97M | $30.10K | $38.65K | — | -39.2% |
| Total assets | $3.58M | $9.34M | $3.12M | $2.44M | — | -61.7% |
| Total current liabilities | $1.38M | $4.32M | $1.41M | $1.45M | — | -68.1% |
| Current debt | $321.45K | $1.94M | $157.52K | $6.94K | — | -83.4% |
| Long-term debt | — | $5.44K | $13.17K | $239.83K | $27.20K | — |
| Total debt | $376.16K | $2.90M | $1.37M | $345.33K | — | -87.0% |
| Total liabilities | $1.38M | $5.12M | $2.43M | $1.71M | — | -73.1% |
| Retained earnings | -$102.08M | -$91.20M | -$82.80M | -$71.84M | — | -11.9% |
| Shareholder equity | $2.20M | $4.22M | $685.95K | $725.02K | — | -47.9% |
| Working capital | $482.63K | $1.29M | -$370.71K | -$29.70K | — | -62.7% |
| Net tangible assets | $999.05K | $2.25M | $655.85K | $686.38K | — | -55.5% |
| Shares issued | 35.85M | 24.18M | 17.06M | 10.95M | — | +48.3% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | -$10.47M | -$8.40M | -$10.96M | -$8.72M | -24.7% |
| Depreciation & amortisation | $542.90K | $353.21K | $126.85K | $114.43K | +53.7% |
| Stock-based compensation | $1.88M | $1.47M | $2.23M | $1.46M | +28.1% |
| Change in working capital | -$895.09K | $277.81K | $171.63K | -$161.68K | -422.2% |
| Operating cash flow | -$6.11M | -$5.32M | -$7.42M | -$6.79M | -14.8% |
| Capital expenditure | -$7.73K | -$563.43K | -$309.10K | -$423.93K | +98.6% |
| Investing cash flow | $11.80K | -$563.43K | -$309.10K | -$423.93K | +102.1% |
| Financing cash flow | $6.07M | $6.03M | $7.34M | $1.59M | +0.7% |
| Free cash flow | -$6.12M | -$5.89M | -$7.73M | -$7.22M | -3.9% |
| End cash position | $200.78K | $227.69K | $87.40K | $475.31K | -11.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $337.57K | $254.72K | $286.11K | $303.28K | $297.50K | +32.5% |
| Operating revenue | $337.57K | $254.72K | $286.11K | $303.28K | $297.50K | +32.5% |
| Cost of revenue | $114.25K | $51.46K | $141.40K | $83.23K | $110.77K | +122.0% |
| Gross profit | $223.32K | $203.25K | $144.71K | $220.06K | $186.73K | +9.9% |
| Research & development | $233.42K | $490.10K | $322.99K | $261.43K | $340.51K | -52.4% |
| Selling, general & admin | $1.60M | $1.67M | $2.01M | $2.02M | $1.69M | -4.6% |
| Total operating expense | $1.83M | $2.17M | $2.34M | $2.29M | $2.03M | -15.4% |
| Operating income | -$1.61M | -$1.96M | -$2.19M | -$2.07M | -$1.84M | +18.0% |
| Net interest income | -$5.04K | -$1.55K | $0 | -$942.44K | -$108.71K | -225.7% |
| Pre-tax income | -$1.61M | -$2.96M | -$2.19M | -$3.01M | -$2.31M | +45.5% |
| Tax provision | $0 | $0 | $0 | $0 | $0 | — |
| Net income | -$1.61M | -$2.96M | -$2.19M | -$3.01M | -$2.31M | +45.5% |
| Net income to common | -$1.74M | -$3.09M | -$2.32M | -$3.13M | -$2.34M | +43.7% |
| Basic EPS | -0.05 | — | -0.07 | -0.11 | -0.10 | — |
| Diluted EPS | -0.05 | — | -0.07 | -0.11 | -0.10 | — |
| EBIT | -$1.61M | -$2.96M | -$2.19M | -$2.07M | -$2.19M | +45.7% |
| EBITDA | -$1.46M | -$2.83M | -$2.06M | -$1.93M | -$2.06M | +48.4% |
| Basic shares | 37.06M | — | 33.67M | 27.58M | 24.30M | — |
| Diluted shares | 37.06M | — | 33.67M | 27.58M | 24.30M | — |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $122.63K | $200.78K | $18.16K | $767.91K | $3.30M | — | -38.9% |
| Cash & short-term investments | $122.63K | $350.78K | $168.16K | $917.91K | $3.45M | — | -65.0% |
| Accounts receivable | $83.79K | $100.84K | $29.86K | $138.00K | $25.95K | — | -16.9% |
| Inventory | $451.33K | $538.37K | $605.39K | $578.29K | $529.34K | — | -16.2% |
| Total current assets | $941.02K | $1.86M | $1.38M | $2.11M | $4.40M | — | -49.4% |
| Property, plant & equipment | $485.74K | $503.59K | $534.19K | $569.20K | $589.65K | — | -3.5% |
| Goodwill & intangibles | $1.08M | $1.20M | $2.45M | $2.57M | $1.87M | — | -10.0% |
| Total assets | $2.67M | $3.58M | $4.38M | $5.26M | $6.89M | — | -25.4% |
| Total current liabilities | $1.31M | $1.38M | $988.42K | $1.05M | $3.12M | — | -4.6% |
| Current debt | $476.46K | $321.45K | — | — | $1.46M | $1.94M | +48.2% |
| Long-term debt | — | — | — | — | $3.43K | $5.44K | — |
| Total debt | $515.11K | $376.16K | $70.56K | $86.32K | $1.57M | — | +36.9% |
| Total liabilities | $1.31M | $1.38M | $997.40K | $1.08M | $3.16M | — | -4.6% |
| Retained earnings | -$103.05M | -$102.08M | -$98.99M | -$96.67M | -$93.54M | — | -1.0% |
| Shareholder equity | $1.36M | $2.20M | $3.38M | $4.18M | $3.73M | — | -38.3% |
| Working capital | -$372.29K | $482.63K | $394.86K | $1.06M | $1.28M | — | -177.1% |
| Net tangible assets | $276.28K | $999.05K | $932.89K | $1.62M | $1.86M | — | -72.3% |
| Shares issued | 37.59M | 35.85M | 34.45M | 32.95M | 24.39M | — | +4.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | -$1.61M | -$2.96M | -$2.19M | -$3.01M | -$2.31M | — | +45.5% |
| Depreciation & amortisation | $150.73K | $135.21K | $134.72K | $139.36K | $133.61K | — | +11.5% |
| Stock-based compensation | $460.61K | $478.84K | $568.46K | $699.40K | $133.20K | — | -3.8% |
| Change in working capital | -$123.23K | $266.78K | -$85.44K | -$910.70K | -$165.74K | — | -146.2% |
| Operating cash flow | -$965.78K | -$812.38K | -$1.47M | -$2.19M | -$1.63M | — | -18.9% |
| Capital expenditure | -$12.37K | — | — | — | — | -$521.20K | — |
| Investing cash flow | -$12.37K | $0 | $5.20K | $6.61K | $0 | — | — |
| Financing cash flow | $900.00K | $995.00K | $711.75K | -$348.08K | $4.71M | — | -9.5% |
| Free cash flow | -$978.15K | -$812.38K | -$1.46M | -$2.21M | -$1.63M | — | -20.4% |
| End cash position | $122.63K | $200.78K | $18.16K | $767.91K | $3.30M | — | -38.9% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2024 | -0.32 | -0.14 | +56.3% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders55.20%
Held by institutions0.13%
Institutions holding1
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
0.80
+2.59% from price
SMA 20
0.77
+7.83% from price
SMA 50
0.71
+15.92% from price
SMA 100
0.75
+10.36% from price
SMA 200
0.80
+3.07% from price
EMA 12
0.78
+5.15% from price
EMA 26
0.76
+8.54% from price
EMA 50
0.74
+10.87% from price
RSI (14)
63.4
Neutral
MACD (12,26,9)
0.02
Hist -0.00
ATR (14)
0.06
7.71% of price
Realised vol 30D
54.8%
Annualised
Bollinger upper
0.89
20, 2σ
Bollinger lower
0.64
20, 2σ
50 / 200 cross
Death
0.71 vs 0.80
Trend bias
Above 200
+3.07%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.46
Less volatile than market
Correlation to SPY
0.08
Largely independent
Realised vol 30D
54.8%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-58.4%
Peak to trough
Max drawdown 5Y
-93.0%
Peak to trough
ATR 14
0.06
7.71% of price
Beta (reported)
1.34
5Y monthly, from filing
Short interest
Shares short
156.28K
Prior 106.30K
Change vs prior
+47.0%
Shorts adding
% of float
1.21%
Normal
% of shares out
0.93%
Against total outstanding
Days to cover
5.1
Crowded exit
Float
26.42M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 21 | ThinkEquity | INITIATED | — | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay dateDec 30, 2020
Last split1:4
Split dateDec 30, 2020
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-22
Corporate Changes & Voting Matters
8-K · 2026-08-20
Periodic Financial Reports
10-Q · 2026-08-14
Corporate Changes & Voting Matters
8-K · 2026-07-29
Corporate Changes & Voting Matters
8-K · 2026-07-27
Periodic Financial Reports
10-K · 2026-06-29
Corporate Changes & Voting Matters
8-K · 2026-06-25
Corporate Changes & Voting Matters
8-K · 2026-06-11
Headlines
Michael Handley Joins PetVivo Holdings, Inc. Board of Directors
GlobeNewswire · 15d ago
Jaime Pickett Joins PetVivo Holdings, Inc. Board of Directors
GlobeNewswire · 15d ago
PETVIVO ANIMAL HEALTH, INC. RELEASES CONFERENCE AND EXHIBIT SCHEDULE FOR 2026-2027
GlobeNewswire · 21d ago
PETVIVO HOLDINGS ANNOUNCES NAME CHANGE OF HUMAN SUBSIDIARY TO SOMATRIX TECHNOLOGIES, INC. AND EXPANDS FOCUS ON HUMAN HEALTH INNOVATION
GlobeNewswire · 48d ago
PetVivo Holdings Inc (PETV) (Q1 2027) Earnings Call Highlights: Revenue Growth and Strategic ...
GuruFocus.com · 50d ago
PetVivo, a Leading Provider of Veterinary Biomedicals, Reports Results for Fiscal Q1 2027
GlobeNewswire · 54d ago
PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET
GlobeNewswire · 61d ago
PETVIVO HOLDINGS ANNOUNCES TERMINATION AND SETTLEMENT AGREEMENT WITH VETSTEM
GlobeNewswire · 71d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.